Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MTTS is a Vietnam-based medical device company and social enterprise focused on affordable technologies for intensive newborn care in low-resource settings. Founded in 2004, the company develops, manufactures, and distributes a suite of neonatal devices marketed under the LifeKit by MTTS brand, including CPAP systems, phototherapy devices, warmers, ventilators, resuscitation equipment, infant beds, and related support tools. Its products are designed to address major causes of preventable neonatal mortality such as respiratory distress, jaundice, thermal instability, and infection risk. MTTS emphasizes clinically informed, cost-effective engineering, quality systems compliant with ISO 13485, and commercialization through distributor networks. The company appears to be revenue-generating and commercially active rather than a therapeutics developer, with its business centered on medtech products for neonatal and maternal-child health care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MTTS.